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ABSTRACT
INTRODUCTION: Corneal and amniotic membrane transplantations are the most frequently performed 
transplantations in the world.  Amniotic membrane transplantation demonstrates very high efficiency in 
the management of the ocular surface damaged by disease or trauma.
AIM: The goal of the current study is to prospectively follow and analyze the tendency in ocular transplan-
tation in a single center in Bulgaria.
MATERIALS AND METHODS: A group of 206 patients were recruited in total for a period of three years. Of 
them 28 had corneal transplantation and 158 had amniotic membrane transplantation. Corneal transplant 
patients were pre-registered on the waiting list and operated as emergency cases due to the short period of 
time in which the corneal material preserves best quality. Patients for amniotic membrane were planned in 
general, but 1/3 were operated as a matter of emergency (102 planned and 56 urgent). The procedures were 
performed following the standard protocols.
RESULTS: The results outline the role of amniotic membrane as a follow-up treatment in 1/3 of the cases. 
After emergency transplantation of amniotic membrane, 12 cases underwent re-operation—corneal trans-
plantation, and 11 received a planned second amniotic membrane transplant. These findings also highlight 
the main advantage of amniotic membrane—absence of graft rejection and possibility for unlimited re-
grafting. Another highlight is the larger number of corneal dystrophies, which underscores the benefits of 
amniotic membrane transplantation not only for comfort but also for visual improvement. 
CONCLUSION: In conclusion, amniotic membrane transplantation in Bulgaria follows the international 
standards, however, corneal transplantation requires revision including the legal regulations, eye bank pro-
tocols, and end-user approaches. In the future, tissue engineering will contribute to the provision of more 
tissue and facilitation of complicated restauration surgeries of the damaged ocular surface. 
Keywords: amniotic membrane transplantation, corneal transplantation, graft rejection, eye bank
Address for correspondence:  
Dimitar Grupchev
Specialized Eye Hospital—Varna 




Corneal and amniotic membrane (AM) trans-
plantations are the most frequently performed trans-
plantations in the world (1,2). The latest tendency is 
to move from penetration to lamellar corneal trans-
plantation. Unfortunately, this trend has not reduced 
the rate of graft rejections in total (3,4). Being a rela-
tively new technique in the ophthalmic practice, am-
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moved in sterile conditions from the container and 
washed with sterile saline (warmed to room tem-
perature). Under a microscope, the membrane is de-
tached from the carrier and placed with the stromal 
part to the anterior ocular surface. After position-
ing and adaptation, 8.0 vicryl is placed as a continu-
ous circular suture with 8 fixation points. The knot 
remains at 6 o’clock. The membrane is washed un-
til it adheres completely to the anterior surface of the 
eye and a therapeutic contact lens (silicone-hydrogel) 
with a moderate modulus is placed in order to ensure 
optimal protection. Antibiotic drops and a bandage 
are applied for at least 60 minutes.
Penetrating corneal graft
The patient is prepared for surgery with gener-
al anesthesia. The position of the head is agreed on 
with the anesthesiologist. It is very important that 
the iris plane be parallel to the floor. After clean-
ing and draping the operating field, the microscope 
is positioned. Baron’s vacuum trephine is used, with 
the donor trephine 0.25 mm larger than the recipient 
size. This is due to the direction of trepanation and 
the tendency for collagen contraction, which leads to 
“contraction” of the donor button and “expansion” of 
the recipient bed.
The donor cornea is prepared first. Thus, in 
case of complications (improper trephination, endo-
thelial damage), the surgery is postponed. The fol-
lowing steps are followed:
Step 1. Trephination of the donor cornea:
  The cornea is removed from the solution and 
drained.
  It is positioned on the platform, where 5 mark-
ing points are placed, the protective ring is 
placed and vacuum is created to hold the cornea.
  The position of the cornea is examined careful-
ly and, if needed, repositioning is done.
  The guillotine is placed and the trephination is 
performed with a sharp pressing.
  The guillotine platform is carefully lifted, the 
corneoscleral ring is removed, and the donor 
button remains attached by the vacuum.
  Vacuum is released and the donor button is 
carefully moved to a sterile transport platform.
niotic membrane transplantation demonstrates very 
high efficiency in the management of the ocular sur-
face damaged by disease or trauma (1,5). Due to re-
cent advances in tissue engineering, now there are 
two distinct trends: to use amniotic membrane as a 
transplant or as a biological product—a carrier for 
ex vivo differentiated cells (6). Nevertheless, applica-
tion of amniotic membrane as a transplant is the pre-
ferred technique in many corneal diseases and espe-
cially after trauma or burns. 
AIM
The aim of this article is to prospectively fol-
low and analyze the trends in ocular transplantation 
in a single center in Bulgaria. The specifics depend 
on the local law and regulations and definitely dif-
fer from other European countries. Such analysis is 
useful not only for the information, but also for de-
scribing the trend and recommending measures for 
improvement. 
MATERIALS AND METHODS
Transplantations were performed by a single 
surgeon at the Specialized Eye Hospital, Varna and 
the patients were prospectively recruited in two co-
horts. A total of 206 patients were recruited for a pe-
riod of three years. Of them 28 had corneal trans-
plantation and 158 had amniotic membrane trans-
plantation. Corneal transplant patients were pre-reg-
istered on the waiting list and operated as emergen-
cy cases due to the short period of time in which the 
corneal material preserves best quality. Patients for 
amniotic membrane are planned in general, but 1/3 
were operated as a matter of emergency (102 planned 
and 56 urgent). 
The procedures were performed following the 
standard protocols described below:
Surgical application of amniotic membrane as 
a cover
The patient is prepared under local anesthe-
sia—3 drops of topical anesthetic (Alcaine col-
lyr 0.5%, 15 mL, Alcon Inc.) every 2 minutes. Af-
ter cleaning the operative field and placing a sterile 
drape, the eyelids are opened with a blade eyelid spec-
ulum and the operative microscope is positioned and 
adjusted. The anterior surface of the eye is cleaned of 
residual debris and polished with a “hockey tool” or 
a polishing sponge. The amniotic membrane is re-
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  The transport platform is moved to the surgi-
cal table and a protective viscous substance is 
placed on the endothelial side.
Step 2. Trepanation of the recipient cornea:
  Before the beginning of the trephination, a side 
incision is made (outside the area of  the sutures 
and a cohesive viscous substance is introduced 
into the anterior chamber).
  First, the trephine is inspected and the 12 points 
of the vacuum platform are marked.
  The center of the trepanation should be deter-
mined in order to achieve an optimal optical 
result.
  Placing the platform and activating the vacu-
um (the knife must be at zero position to have 
control over the thickness of penetration—a 
quarter turn corresponds to advancement of 50 
microns).
  Trepanation with slow rotation of the trephine 
is performed in a clockwise direction.
  At the appearance of a sign of penetration, im-
mediate release of the vacuum is done.
  The trepanation is finished with a knife or cor-
neal scissors.
Step 3. Adaptation of the donor cornea to the 
recipient bed (except for the cases of combined sur-
gery, which is not the subject of this statement):
  The graft is transferred with a special spatula 
and placed in the recipient bed.
  Four cardinal stitches are placed in order to 
achieve optimal adaptation.
  The remaining 16 stitches are placed 
sequentially.
  The anterior chamber is washed.
  Intracameral and subconjunctival antibiotics 
are applied.
In case of intraoperative deviations and com-
plications, specific measures were taken, and patient 
was excluded from the group. In most cases a non-
transparent bandage was used for at least 12 hours.
RESULTS
Demographic characteristics and structure of 
the indications are presented in Table 1. After emer-
gency transplantation of amniotic membrane, 12 
cases underwent re-operation—corneal transplan-
tation, and 11 received a planned second amniotic 
membrane transplant. The results outline the role of 
amniotic membrane as a follow-up treatment in 1/3 
Characteristics AM Transplantation Corneal Transplantation
Total number 158 28
Number treated as emergency 56 4
Sex Male 77 Female 81
Male 12 
Female 16
Age 47 ± 17 52 ± 12
Citizens of Varna region 56 11





















Chronology of the treatment Primary 101Follow-up 57
Primary 25
Follow-up 3
Table 1. Patients receiving transplantation of amniotic membrane(AM) or cornea for period of three years (May 2016–
May 2019)—demographic and clinical characteristics.
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of cases. These findings also highlight the main ad-
vantage of amniotic membrane—absence of graft re-
jection and possibility for unlimited re-grafting. An-
other highlight is the larger number of corneal dys-
trophies, which underscores the benefit amniotic 
membrane transplantation not only for comfort but 
also for visual improvement. Number one indication 
in case of dystrophy is recurrent erosion syndrome. 
Another benefit of amniotic membrane is availabil-
ity, which explains why some of the perforations are 
first treated with AM transplantation. In the eyes 
followed in these studies the outcome measures were 
not only mechanical stabilization but also anti-in-
flammatory and anti-proliferative properties (Fig. 1). 
DISCUSSION
Corneal transplantation is relatively rare in 
comparison to amniotic membrane transplanta-
tion, which was confirmed by the current single-cen-
ter study (7). Corneal transplantation restores visual 
function, especially when the ocular surface is sig-
nificantly affected, but depends very much on the 
retrospective consequences and restauration of the 
normal anatomical relationships between lids, cor-
nea, and conjunctiva (8,9). Apart from the National 
Transplantation Registry, currently there is a limited 
information about indications and outcomes of cor-
neal transplantation in Bulgaria. Mostly the outcome 
measures are based on the graft rejection, which is an 
important issue but has limited value for evaluation 
of quality of vision and life of the entire population 
with ocular transplantation (10–12). 
Another important issue that must be dis-
cussed is the availability of corneal material. In gen-
eral, in Bulgaria the eye banks work with limited ef-
ficiency and disrupted collaboration. One donor is a 
source of material for only 2 transplantations. This 
has a regulatory background as well, as the reim-
bursement of the transplanting institutions is based 
not on the surgical protocols but on eye bank invoic-
es. Moreover, importing tissue from a bank outside 
the national borders is difficult, very complicated, 
and rarely practiced. This is an international prob-
lem, as discussed by Martin DE et al. (13). Howev-
er, the good European eye banking practice requires 
tissue processing, proper register for tissue exchange, 
and efficient electronic system, which allows alloca-
tion and follow-up on all donors and recipients (14). 
Internationally the eye banks are working on proper 
manufacturing of the material. Three transplants are 
usually prepared from one donor: Descemet mem-
brane endothelial keratoplasty (DMEK) transplant 
pre-loaded, diffuse lamellar keratitis (DLK) button 
and limbal stem cell transplant for at least one recipi-
Fig. 1. Clinical photography of a patient with crystalline corneal dystrophy of Schneider (а) and the result after 
superficial keratectomy and AM transplantation (b). 
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ent. In case of the planned penetrating keratoplasty, 
the limbal stem cells are the second product out of 
one cornea. Considering the insufficiency of corne-
al tissue, this is a more efficient and rational way of 
eye banking.
Nevertheless, corneal tissue is more difficult 
to acquire, process, store, and distribute. This is the 
main explanation why amniotic membrane is now 
more often performed. Human AM has anti-adhe-
sive properties, promotes epithelialization, decreases 
inflammation, neovascularization, and fibrosis, but 
still cannot replace corneal transplantation. The out-
come from the current study highlights three main 
applications of AM:
  emergency solution in case of perforation or 
impeding perforation;
  preparation for corneal transplantation or en-
hancement of the ocular surface after penetra-
tion graft;
  restauration of the ocular surface and 
conjunctiva. 
The current study highlights the latter as the 
most common indication, but the first one as the 
most crucial for successful visual outcome. In a study 
in Mexico that lasted eight years, Chávez-García et 
al., including a detailed protocol of the donor selec-
tion, tissue harvesting, preparation, storage and dis-
tribution of amniotic membrane, described the indi-
cations of AM transplantation of a total of 1686 am-
niotic membrane fragments used during that period 
(15). The five most common indications for amniot-
ic membrane transplantation were pterygium, corne-
al ulcers, conjunctival surface repair, neoplasms, and 
persistent epithelial defects. They compared the in-
dications of amniotic membrane use in two different 
types of institutions: general hospitals and ophthal-
mologic reference hospitals. It is surprising to find 
interesting differences between the indications and 
use rates between these institutions. There was up to 
a fivefold increase in the use of amniotic membrane 
for correction of persistent epithelial defects in ref-
erence hospitals, which could be explained with the 
more complex and severe ophthalmological patholo-
gies admitted in reference hospitals (15). In both in-
stitutions the most often indication for AM trans-
plantation was pterygium. 
Amniotic membrane has different advantag-
es and disadvantages. The way that amniotic mem-
brane is utilized in Bulgaria is as a transplant, which 
is quite restrictive not only for outpatients but also 
for some surgical departments. In order to perform 
transplantation, the center must be accredited fol-
lowing special rules and procedures. This limits the 
possibility for utilization of this efficient and very 
effective method of biological treatment. In many 
countries in Europe there is a regulation for biolog-
ical products which can be used in outpatient prac-
tices. For example, there are a number of products 
attached or supported by contact lenses, which does 
not require suturing. The aforementioned approach 
is not only non-invasive but also cost-efficient and 
easily repeatable on demand. 
CONCLUSION
In conclusion, amniotic membrane transplan-
tation in Bulgaria is according to the international 
standards, however, corneal transplantation requires 
revision including the legal regulations, eye bank 
protocols and end user approaches. In the future, tis-
sue engineering will contribute to the provision of 
more tissue and facilitation of complicated restaura-
tion surgeries of the damaged ocular surface. 
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